共 50 条
- [1] The Efficacy and Safety of Cladribine in Combination with Cytarabine,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter StudyBLOOD, 2019, 134Zhang, TinghuaXie, YinghuaZhao, LiminHan, XiyaoLu, YingtingZhang, JingXie, YanhuiZhu, QiSun, LihuaYang, LiLiu, Ligen
- [2] Efficacy and Safety of Decitabine in Combination with G-CSF, Low-Dose Cytarabine and Mitoxantrone in Pediatric Refractory and Relapse Acute Myeloid Leukemia and MDS-RaebtBLOOD, 2018, 132Fan, LiyanChen, AiliHu, YixinXiao, PeifangLu, JunLi, JieHe, HailongWang, YiHu, Shaoyan
- [3] Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemiaONCOTARGET, 2015, 6 (08) : 6448 - 6458Li, JianyongChen, YaoyuZhu, YuZhou, JianfengXu, YanliLi, YanYu, KangPan, LingWang, JianminDing, JiahuaGu, JianZhou, ShanhuaShi, JinningHong, MingXu, JiPan, LiangqinDuan, LiminZhang, RunZhang, SujiangZhu, HuayuanLu, HuaLiu, PengQiu, HongxiaWu, HanxinQian, Sixuan
- [4] Efficacy and safety of venetoclax in combination with cytarabine and azacitidine (VAA) in relapsed/refractory acute myeloid leukemia: An open-label, single-arm, phase II study.JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)You, LiangshunLiu, YiMai, WenyuanZhou, DeXie, WanzhuoMao, LipingZhou, XinpingTong, HongyanJin, JieMeng, Haitao
- [5] Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemiaLEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 121 - 129Robak, TWrzesien-Kus, ALech-Maranda, EKowal, MDmoszynska, A
- [6] Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemiaFRONTIERS IN ONCOLOGY, 2022, 12Zhu, Jun-FengDai, Hai-PingZhang, Qian-QianYin, JiaLi, ZhengCui, Qin-YaTian, Xiao-PengLiu, Si-NingJin, Zheng-MingZhu, Xia-MingWu, De-PeiTang, Xiao-Wen
- [7] Efficacy and Safety of Azacytidine in Combination With Fludarabine and High-Dose Cytarabine With G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II StudyCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (10): : 720 - 723Motabi, Ibraheem H.Al Aoun, Shaima M.Al-Ammari, MagedAlbtoosh, Belal M.Iqbal, ShahidAltaf, Syed Y.Tailor, Imran K.Alnoamani, Mohammed S.AlGhamdi, Mubarak S.Zaidi, Syed Z. A.AlShehry, Nawal F.Marei, Mohammed A.Alfayez, Mansour
- [8] Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid LeukemiaBLOOD, 2023, 142Yu, Wen-JingWu, YingChen, QiZhu, XiaoluPei, Xu-YingJia, Jin-SongWang, JingZhao, Xiao-SuChang, Ying-JunLai, Yue-YunShi, Hong-XiaRuan, Guo-RuiQin, Ya-ZhenLiu, Xiao-HongHuang, Xiao JunJiang, Hao
- [9] Efficacy and safety of G-CSF, low-dose cytarabine and aclarubicin in combination with L-asparaginase, prednisone in the treatment of refractory or relapsed acute lymphoblastic leukemiaLEUKEMIA RESEARCH, 2017, 62 : 29 - 33Zhou, KeshuSong, YongpingZhang, YanliWei, XudongFu, YuewenYu, FengkuanZhou, HuLiu, XinjianZhou, JianFang, Baijun
- [10] A phase II study with decitabine, low-dose cytarabine and G-CSF priming in high-risk myelodysplastic syndromes, refractory/relapsed acute myelogenous leukemia or acute myeloid leukemia in patients with significant comorbiditiesJOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Butera, J.Winer, E.Wang, C.Castillo, J. J.Thomas, A. G.Safran, H.Mega, A. E.Colvin, G. A.Rathore, B.Quesenberry, P. J.